Cover Image
Market Research Report

Global Sexually Transmitted Disease (STD) Testing Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 317317
Published Content info 129 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Sexually Transmitted Disease (STD) Testing Market 2019-2023
Published: July 23, 2019 Content info: 129 Pages
Description

About this market

Sexually transmitted disease testing (STD) is used for quantitative analysis of viruses causing sexual diseases. Technavio's sexually transmitted disease testing market analysis considers sales from laboratory testing devices and point of care (POC) testing devices segments. Our analysis also considers the sales of sexually transmitted disease testing in Asia, Europe, North America, and ROW. In 2018, the laboratory testing devices segment held the highest market share, which is expected to remain prevalent over the forecast period. The rising need for STD tests and screening owing to the increasing incidence of HIV will significantly help the laboratory testing devices segment in maintaining its leading market position. Also, our global sexually transmitted disease testing report has observed market growth factors such as increased initiatives by governments worldwide, the presence of favorable reimbursement policies, and increasing prevalence of STDs. However, the social stigma associated with STDs, high cost of novel treatments, and limited healthcare services in developing regions may hamper the growth of the sexually transmitted disease testing industry over the forecast period.

Overview

Increased initiatives by governments worldwide

Governments have been increasingly organizing awareness programs about STDs, their diagnosis methods, and treatment to prevent them from spreading. As a result, the sales of STD testing kits have increased. This will lead to the expansion of the global sexually transmitted disease testing market at a CAGR of almost 9% during the forecast period.

Advances that enable the rapid diagnostics of STDs

Vendors are increasingly offering rapid point of care (POC) testing kits that provide accurate results within 15-20 minutes. They are also developing advanced diagnostic techniques to screen human papillomavirus (HPV). Such advances in products offerings will increase sales. As a result, the trend will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global sexually transmitted disease testing market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global sexually transmitted disease testing market is moderately fragmented. Technavio's robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease testing manufacturers, which include Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and F. Hoffmann-La Roche Ltd.

Also, the sexually transmitted disease testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Table of Contents
Product Code: IRTNTR31739

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Laboratory testing devices - Market size and forecast 2018-2023
  • POC testing devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increasing involvement of various organizations to create awareness
  • about STDs
  • Advances that enable the rapid diagnosis of STDs
  • Approval of drugs and strong drug pipeline

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Laboratory testing devices - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 21: Laboratory testing devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: POC testing devices - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 23: POC testing devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Europe - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Asia - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: ROW - Market size and forecast 2018-2023 ($ billions)
  • Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Abbott Laboratories - Vendor overview
  • Exhibit 45: Abbott Laboratories - Business segments
  • Exhibit 46: Abbott Laboratories - Organizational developments
  • Exhibit 47: Abbott Laboratories - Geographic focus
  • Exhibit 48: Abbott Laboratories - Segment focus
  • Exhibit 49: Abbott Laboratories - Key offerings
  • Exhibit 50: bioMerieux SA - Vendor overview
  • Exhibit 51: bioMerieux SA - Product segments
  • Exhibit 52: bioMerieux SA - Organizational developments
  • Exhibit 53: bioMerieux SA - Geographic focus
  • Exhibit 54: bioMerieux SA - Key offerings
  • Exhibit 55: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 56: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 57: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 58: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 59: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 60: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 61: Danaher Corp. - Vendor overview
  • Exhibit 62: Danaher Corp. - Product segments
  • Exhibit 63: Danaher Corp. - Organizational developments
  • Exhibit 64: Danaher Corp. - Geographic focus
  • Exhibit 65: Danaher Corp. - Segment focus
  • Exhibit 66: Danaher Corp. - Key offerings
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 68: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 69: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 70: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 71: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 72: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 73: Validation techniques employed for market sizing
  • Exhibit 74: Definition of market positioning of vendors
Back to Top